Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France

Linezolid is one of the most effective drugs for treating multidrug-resistant tuberculosis (MDR TB), but adverse effects remain problematic. We evaluated 57 MDR TB patients who had received >1 dose of linezolid during 2011–2016. Overall, patients received 600 mg/day of linezolid for a median of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaspard, Marie, Butel, Nathalie, El Helali, Najoua, Marigot-Outtandy, Dhiba, Guillot, Helene, Peytavin, Gilles, Veziris, Nicolas, Bodaghi, Bahram, Flandre, Philippe, Petitjean, Gregoire, Caumes, Eric, Pourcher, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392460/
https://www.ncbi.nlm.nih.gov/pubmed/32687026
http://dx.doi.org/10.3201/eid2608.191499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392460/
https://www.ncbi.nlm.nih.gov/pubmed/32687026
http://dx.doi.org/10.3201/eid2608.191499

Ejemplares similares